Free Trial

Vanguard Group Inc. Acquires 1,289,183 Shares of Teladoc Health, Inc. $TDOC

Teladoc Health logo with Medical background

Key Points

  • Vanguard Group Inc. increased its holdings in Teladoc Health, Inc. by 7.0% during the first quarter, owning approximately 11.26% of the company with a market value of $157.23 million.
  • Teladoc Health reported earnings of ($0.19) EPS for the latest quarter, surpassing analysts' expectations, but showed a 1.6% decline in revenue year-over-year.
  • Institutional investors own 76.82% of Teladoc Health's stock, with various hedge funds significantly increasing their holdings during the first quarter of this year.
  • Interested in Teladoc Health? Here are five stocks we like better.

Vanguard Group Inc. grew its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 7.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,752,338 shares of the health services provider's stock after purchasing an additional 1,289,183 shares during the period. Vanguard Group Inc. owned about 11.26% of Teladoc Health worth $157,229,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Cambridge Investment Research Advisors Inc. increased its position in Teladoc Health by 60.8% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock worth $316,000 after purchasing an additional 15,030 shares during the last quarter. Golden State Wealth Management LLC increased its position in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after purchasing an additional 1,690 shares during the last quarter. Wedmont Private Capital increased its position in Teladoc Health by 20.3% in the 1st quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock worth $117,000 after purchasing an additional 2,715 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its position in Teladoc Health by 22.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock worth $134,000 after purchasing an additional 2,662 shares during the last quarter. Finally, Vontobel Holding Ltd. increased its position in Teladoc Health by 61.4% in the 1st quarter. Vontobel Holding Ltd. now owns 21,422 shares of the health services provider's stock worth $171,000 after purchasing an additional 8,152 shares during the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Price Performance

Shares of NYSE TDOC traded up $0.16 during midday trading on Tuesday, reaching $7.83. 7,835,093 shares of the company traded hands, compared to its average volume of 7,158,000. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. The stock's 50-day simple moving average is $7.76 and its 200-day simple moving average is $8.14. The firm has a market cap of $1.38 billion, a PE ratio of -6.58 and a beta of 1.76.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The company had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. During the same quarter in the previous year, the company earned ($0.38) EPS. The firm's revenue for the quarter was down 1.6% compared to the same quarter last year. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, equities analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Analysts Set New Price Targets

TDOC has been the subject of several recent analyst reports. Wells Fargo & Company decreased their price target on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research note on Thursday, May 8th. Evercore ISI raised their price objective on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 9th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Stifel Nicolaus cut their target price on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research note on Thursday, May 1st. Finally, Bank of America cut their target price on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research note on Wednesday, May 28th. Six equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. According to MarketBeat, Teladoc Health has a consensus rating of "Hold" and a consensus price target of $9.80.

Get Our Latest Research Report on TDOC

Insiders Place Their Bets

In other news, insider Fernando M. Rodrigues sold 4,174 shares of the business's stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total value of $28,842.34. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Carlos Nueno sold 3,958 shares of the stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $27,151.88. Following the sale, the insider owned 17,645 shares in the company, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 18,656 shares of company stock valued at $128,189. 0.58% of the stock is currently owned by insiders.

Teladoc Health Profile

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Further Reading

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Should You Invest $1,000 in Teladoc Health Right Now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.